Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic;Diagnóstico, manejo y tratamiento de la cardiopatía chagásica crónica en áreas donde la infección por Trypanosoma cruzi no es endémica

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue 2, 2008, Pages 99-106

  Gascón, Joaquim ^a   Albajar, Pedro ^b   Cañas, Elías ^c   Flores, María ^d   Prat, Jordi Gómez ^e   Herrera, Ramón N ^f   Lafuente, Carlos A ^g   Luciardi, Héctor L ^f   Moncayo, Álvaro ^h   Molina, Lluís ⁱ   Muñoz, José ^a   Puente, Sabino ^j   Sanz, Ginés ^k   Treviño, Begoña ^e   Sergio Salles, Xavier ^l  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e ICS   (Spain)

^f UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^g Hospital Universitario Japonés   (Bolivia)

^h UNIVERSIDAD DE LOS ANDES   (Colombia)

ⁱ HOSPITAL DEL MAR   (Spain)

^j HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^k CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^l Funda??o Oswaldo Cruz   (Brazil)

more..

Author keywords

Arrhythmia; Chagas' disease; Heart disease; Sudden death

Indexed keywords

ANGIOCARDIOGRAPHY; CHAGAS DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; ELECTROCARDIOGRAPHY MONITORING; HEART ARRHYTHMIA; HEART MUSCLE BIOPSY; HOLTER MONITORING; HUMAN; MEDICAL EXAMINATION; PATIENT ASSESSMENT; PATIENT CARE; SUDDEN DEATH; THORAX RADIOGRAPHY; TRYPANOSOMA CRUZI;

EID: 39449130771     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13115545     Document Type: Conference Paper

References (64)

1. Segundo Informe del Comité de Expertos sobre control de la Enfermedad de Chagas, Serie de Informes Técnicos 905. Geneva: OMS 2003. p. 74, 75 y 92.
2. Moncayo A. Current epidemiological trends after the interruption of vectorialnd transfusional tranmission of Chagas disease in the Southern Cone countries. Mem Inst Oswaldo Cruz, Rio de Janeiro, 2003;58:577-91.
3. Sistema Nacional de Información en Salud. Boletín de Vigilancia Semanal. La Paz, julio 2006. Disponible en: www.paho.org/Spanish /DD/PIN/ps060616.htm 4. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001;1:92-100.
4. Valente AS, Valente VC, Frahia-Neto H. Considerations on the epidemiology and transmisión of Chagas disease in the Brazilian Amazon. Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:395-8.
5. Schmunis GA. American trypanosomiasis and its impact on public health in the Americas. En: Brener Z, Andrade ZA, Barral-Neto M, editors. Trypanosoma cruzi e Doença de Chagas. Rio de Janeiro: Guanabara Koogan; 2000. p. 1-20.
6. Hayes R, Schofield C. Estimación de tasas de incidencia de infecciones y parasitosis crónica a partir de la prevalencia: la enfermedad de Chagas en América Latina. Bol Ofic Sanit Panam. 1990;108:308-16.
7. Sztajzel J, Cox J, Pache JC, Badaoui E, Lerch R, Rutishauser W. Chagas' disease may also be encountered in Europe. Eur Heart J. 1996;17:1289.
8. Ueno Y, Nakamura Y, Inoue T, Endo S, Kinoshita M, Takeuchi T. A highly suspected case of chronic Chagas'heart disease diagnosed in Japan. Jpn Circ J. 1995;59:219-23.
9. Publicado en: http://extranjeros.mtas.es/es/general/tabla2_dic05.html
10. Muñoz J, Ávila E, Alonso D, Treviño B, Gómez J, Sanz G, et al. Características clínicas de pacientes infectados por Trypanosoma cruzi. Enf Emerg. 2006;8 Suppl 1:42-4.
11. Baruch WA, Arribada JA, Bulla DH, Carlier Y, Rodrigues J, Chuit R, et al. Consulta Técnica Regional OPS/MSF sobre Organização e estrutura da atenção médica do doente e infectado por Trypanosoma cruzi/doença de Chagas. Rev Soc Bras Med Trop. 2005;38:538-41.
12. Dias JCP. Natural history of Chagas' disease. Arq Bras Cardiol. 1995;65:359-66
13. Bellotti G, Bocchi EA, De Moraes AV, Higuchi ML, Barbero-Marcial M, Sosa E, et al. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Am Heart J. 1996;131:301-7.
14. Higuchi ML, De Brito T, Reis MM, Barbosa A, Bellotti G, Pereira-Barreto AC, et al. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc Pathol. 1993;2:101-6.
15. Takle GB, Hudson L. Autoimmunity and Chagas' disease. Curr Top Microbiol Immunol. 1989;145:79-92.
16. López L, Arai K, Jiménez E, Jiménez M, Pascuzo C, Rodríguez-Bonfante C, et al. C-Reactive Protein and Interleukin-6 serum levels increase as Chagas disease progreses towards cardiac failure. Rev Esp Cardiol. 2006;59:50-6.
17. Rossi MA. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am Heart J. 1990;120:233-6.
18. Tafuri WL. Immunopathology of Chagas disease: a historical overview. Mem Inst Oswaldo Cruz. 1999;99 Supl:247-8.
19. Marin-Neto JA. Cardiac dysautonomia and pathogénesis of Chagas' heart disease. Int J Cardiol. 1998;66:129-31.
20. Dávila-Spinetti DF, Colmenarez-Mendoza HL, Lobo-Vielma L. Mecanismos causantes de la progresión del daño miocárdico en la enfermedad de Chagas crónica. Rev Esp Cardiol. 2005;58:1007-9.
21. Viotti R, Vigliano C, Lococo B, Petti M, Bertocchi G, Álvarez MG, et al. Indicadores clínicos de progresión de la miocaditis chagásica crónica. Rev Esp Cadiol. 2005;58:1037-44.
22. Chagas C. Pathogenic processes of American trypanosomiasis. Mem Inst Oswaldo Cruz. 1916;8:3-38.
23. Prata A. Prognóstico e complicações da doença de Chagas. Rev Goiana Med. 1959;5:87-96.
24. Simoes MV, Nonino A, Simoes BP, Almeida-Filho OC, Maciel BC, Marin-Neto JA. Reagudization of Chagas myocarditis inducing exclusive right ventricular failure. Arq Bras Cardiol. 1994;62:435-7.
25. Gascon J. Diagnóstico y tratamiento de la enfermedad de Chagas importada. Documento de consenso. Med Clin (Barc). 2005;125: 230-5.
26. Achotegui J. Emigration in hard conditions: the Immigrant Syndrome with chronic and multiple stress (Ulysses' Síndrome). Vertex. 2005;16:105-13.
27. Laranja FS, Dias E, Nobrega G, Miranda A. Chagas' disease: a clinical, epidemiologic, and pathologic study. Circulation. 1956;14:1035-60.
28. Maguire JH, Hoff R. Cardiac morbidity and mortality due to Chagas disease: prospective eletrocardiographic study of a brazilian community. Circulation. 1987;75:1140-5.
29. Dias JCP, Kloetzel K. The prognostic value of the electrocardiographic features of chronic Chagas'disease. Rev Inst Med Trop São Paulo. 1968:10:158-62.
30. Sousa AS, Xavier SS, Pereira JB, Roy LO, Alvarenga G, Mallet ALR, et al. Predictive models of moderate or severe systolic dysfunction in Chagas' disease based on clinical, electrocardiographic and radiological data. Rev Bras Eco. 2001;14:63-71.
31. Garcia MI, Sousa AS, Hasslocher-Moreno A, Mallet ALR, Xavier SS. Valor prognóstico da largura do QRS na cardiopatia chagásica crônica com disfunção ventricular moderada a grave. Rev Bras Eco. 2003;16:53-9.
32. Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of a simple risk score for predicting mortality in Chagas'heart disease. N Engl J Med. 2006; 355:799-808.
33. Acquatella H, Schiller NB, Puigbó JJ, Suárez JA, Casal H. M-mode and two-dimensional echocardiography in chronic Chagas' heart disease. A clinical and pathologic study. Circulation. 1980;62:787-99.
34. Xavier SS, Hasslocher-Moreno A, Pirmes C, Borges J, Barroso J, Barroso PF. Echocardiographic features of chronic Chagas' Herat diseases. J Am Coll Cardiol. 1997;29:223A.
35. Siciliano APRV, Hasslocher-Moreno A, Sousa AS, Brasil PEAA, Holanda MT, Garcia MI, et al. Padrão da função diastólica e relação com a gravidade da forma clínica em 902 pacientes na fase crónica da enfermedad de Chagas. Rev Socerj. 2006;19:75-84.
36. Combellas I, Puigbo JJ, Acquatella H, Tortoledo F, Gomez JR. Echocardiographic features of impaired left ventricular diastolic function in Chagas's heart disease. Br Heart J. 1985;53:298-309.
37. Xavier SS, Sousa AS, Alencar AT, Borges-Pereira J, Hasslocher-Moreno A. Nova proposta de classificação do acometimento cardíaco na fase crônica da doença de Chagas com uso do ecocardiograma. Rev Bras Eco. 2000;13:3:59-65.
38. Nunes MCP, Barbosa MM, Rocha MOC. Valor prognostico da disfunção diastólica em pacientes com miocardiopatia dilatada chagásica. Rev Bras Eco. 2004;17:15-22.
39. Ribeiro ALP, Lombardi F, Sousa MR, Barros MVL, Porta A, Barros VCV, et al. Power-law behavior of heart rate variability in Chagas' disease. Am J Cardiol. 2002;89:414-8.
40. Rassi A Jr, Rassi AG, Rassi SG, Rassi C Jr, Rassi A. Frequência e grau de extra-sistolia ventricular à eletrocardiografia dinâmica (sistema Holter de 24 horas) na doença de Chagas. Arq Bras Cardiol. 1991;57 Suppl C:C134.
41. Salles G, Xavier SS, Sousa AS, Hasslocher-Moreno A, Cardoso C. Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease. Results of a long-term follow-up study. Circulation. 2003;108:305-12.
42. Espulgas E, Alfonso F, Alonso JJ, Asín E, Elizaga J, Iñiguez A, et al. Guías de práctica clínica de la Sociedad Española de Cardiología en cardiología intervencionista: angioplastia coronaria y otras técnicas. Rev Esp Cardiol. 2000;53:218-40.
43. Espinosa R, Pericci L, Carrasco HA, Escalante A, Martínez O, González R. Prognostic indicators in chronic chagasic cardiopathy. Int J Cardiol. 1991;30:195-202.
44. Macedo V. Forma indeterminada da doença de Chagas. J Bras Med. 1980;38:34-40.
45. Dias JC. The indeterminate form of human chronic Chagas' disease. A clinical epidemiological review. Rec Soc Bras Med Trop. 1989;22:147-56.
46. Sousa AS. Modelos preditivos de disfunção moderada ou grave na enfermedad de Chagas, baseados em dados clínicos, eletrocardiográficos e radiológicos. Tese de Mestrado. Faculdade de Medicina, UFRJ, Rio de Janeiro. 2000.
47. Xavier SS, Sousa AS, Hasslocher-Moreno A. Aplicação da nova classificação da insuficiencia cardíaca (ACC/AHA) na cardiopatia chagásica crónica: Análise crítica das curvas de sobrevida. Rev Socerj. 2005;18:227-32.
48. Xavier SS, Sousa AS, Mallet ARL, Hasslocher-Moreno A. Progressão da lesão miocardica na doença de Chagas: um estudo ecocardioográfico. Arq Bras Cardiol. 2004;83 Suppl 3:127.
49. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection. N Engl J Med. 1992;327: 685-91.
50. Prata A, Lopes ER, Chapadeiro E. Características da morte súbita tida como não esperada na doença de Chagas. Rev Soc Bras Med Trop. 1986;19:9-12.
51. Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol. 2001;76:75-96.
52. Chiale PA, Halpern MS, Nau GJ, Tambussi AM, Przybylski J, Lázzari JO, et al. Efficacy of amiodarone during long term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis. Am Heart J. 1984;107:656-65
53. Bocchi EA, Bellotti G, Mocelin AO, Uip D, Bacal F, Higuchi ML, et al. Heart transplantation for chronic Chagas' heart disease. Ann Thorac Surg. 1996;61:1727-33.
54. Herrera RN, Díaz E, Pérez R, Chaín S, Sant-Yacumo Rodriguez E, Bianchi J, et al. Estado protrombóitico en estadios tempranos de la enfermedad de Chagas crónica. Rev Esp Cardiol. 2003;56: 377-82.
55. Oliveira J, Correa de Araujo R, Navarro M, Muccillo G. Cardiac trombosis and thromboembolism in chronic Chagas' disease. Am J Cardiol, 1983;52:147-51.
56. Sousa AS, Xavier SS, Freitas GR, Mallet AL, Hasslocher-Moreno A. Estratégias de prevenção do acidente vascular encefálico cardioembólico na doença de Chagas. Arq Bras Cardiol. 2006. En prensa.
57. Oliveira JS, Mello de Oliveira JA, Frederigue U Jr, Lima Filho EC. Apical aneurysm of Chagas' heart disease. Br Heart J. 1981; 46:432-7.
58. Sarabanda A, Sosa E, Scanavacca M, Magalhäes L, Kuniyoshi R, Darrieux F, et al. Correlação entre a morfologia da taquicardia ventricular sustentada e a ventriculografia esquerda na cardiopatia chagásica crônica. Rev Bras Marcapasso e Arritmias. 1994; 7:143.
59. Sosa E, Scalabrini A, Rati M, Bellotti G, Pileggi F. Successful catheter ablation of the "origin" of recurrent ventricular tachycardia in chronic chagasic heart disease. J Electrophysiol. 1987;1:58-61.
60. Sosa E, Scanavacca M, D'Avila A, Bellotti G, Pilleggi F. Radiofrequency catheter ablation of ventricular tachycardia guided by nonsurgical epicardial mapping in chronic chagasic heart disease. Pace. 1999;22:128-30.
61. Ferreira HO. Tratamento da forma indeterminada da doença de Chagas com Nifurtimox e benznidazol. Rev Soc Bras Med Trop. 1990;23:209-11.
62. Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Álvarez MG, et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment. Ann Int Med. 2006;144:724-34.
63. Consenso de Enfermedad de Chagas. Rev Argent Cardiol. 2002;70 Suppl 1:9-86 [accedido 1 Dic 2006]. Disponible en: www.soc.org.ar/consensos/htm
64. Consenso Brasileiro em doença de Chagas. Rev Soc Bras Med Trop. 2005;38 Suppl 3:7-29 [accedido el 1 Dic 06]. Disponible en: www.parasitologia. org.br/atualidades/consenso_chagas.pdf